Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

BACKGROUND: We investigated low-dose aspirin (ASA) efficacy and safety in subjects with silent brain infarcts (SBIs) in preventing new cerebrovascular (CVD) events as well as cognitive impairment. METHODS: We included subjects aged ≥45 years, with at least one SBI and no previous CVD. Subjects were...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestrini, Ilaria, Altieri, Marta, Di Clemente, Laura, Vicenzini, Edoardo, Pantano, Patrizia, Raz, Eytan, Silvestrini, Mauro, Provinciali, Leandro, Paolino, Isabella, Marini, Carmine, Di Giuseppe, Matteo, Russo, Tommasina, Federico, Francesco, Coppola, Cristiana, Prontera, Maria Pia, Mezzapesa, Domenico Maria, Lucivero, Vincenzo, Parnetti, Lucilla, Sarchielli, Paola, Peducci, Maria, Inzitari, Domenico, Carlucci, Giovanna, Serrati, Carlo, Zat, Carla, Cavallini, Anna, Persico, Alessandra, Micieli, Giuseppe, Bastianello, Stefano, Di Piero, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192130/
https://www.ncbi.nlm.nih.gov/pubmed/30402216
http://dx.doi.org/10.1155/2018/7532403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192130/
https://www.ncbi.nlm.nih.gov/pubmed/30402216
http://dx.doi.org/10.1155/2018/7532403

Ejemplares similares